Shuntarou Tsuchiya

Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma

Akito Nakamura, Takeo Arita, Shuntarou Tsuchiya et al. · Cancer Research · 2013 · 126 citations

Medicine, Oncology, Pharmacology +17

Non‐alcoholic steatohepatitis‐associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge

Yuichiro Amano, Fumi Shimizu, Hironobu Yasuno et al. · Hepatology Research · 2016 · 22 citations

Medicine, Nutrition, Nutritional Sciences +17

Anti‐angiogenic and anti‐tumor effects of <scp>TAK</scp>‐593, a potent and selective inhibitor of vascular endothelial growth factor and platelet‐derived growth factor receptor tyrosine kinase

Yoshiko Awazu, Akio Mizutani, Yoshinori Nagase et al. · Cancer Science · 2013 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis

Yuichiro Amano, Shuntarou Tsuchiya, Mayumi Imai et al. · Biochemical and Biophysical Research Communications · 2018 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +13

Pharmacological evaluation of pioglitazone and candesartan cilexetil in a novel mouse model of non‐alcoholic steatohepatitis, modified choline‐deficient, amino acid‐defined diet fed low‐density lipoprotein receptor knockout mice

Shuntarou Tsuchiya, Yuichiro Amano, Osamu Isono et al. · Hepatology Research · 2016 · 10 citations

Medicine, Pharmacology, Pharmacotherapy +14